Annual FCF
-$247.49 M
+$33.51 M+11.93%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual free cash flow is -$247.49 million, with the most recent change of +$33.51 million (+11.93%) on December 31, 2023.
- During the last 3 years, ARQT annual FCF has fallen by -$134.13 million (-118.33%).
- ARQT annual FCF is now -6455.89% below its all-time high of -$3.77 million, reached on December 31, 2017.
Performance
ARQT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$34.83 M
+$10.29 M+22.80%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly free cash flow is -$34.83 million, with the most recent change of +$10.29 million (+22.80%) on September 30, 2024.
- Over the past year, ARQT quarterly FCF has increased by +$9.22 million (+20.92%).
- ARQT quarterly FCF is now -379.96% below its all-time high of -$7.26 million, reached on March 31, 2019.
Performance
ARQT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$167.80 M
+$9.22 M+5.21%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM free cash flow is -$167.80 million, with the most recent change of +$9.22 million (+5.21%) on September 30, 2024.
- Over the past year, ARQT TTM FCF has increased by +$94.62 million (+36.06%).
- ARQT TTM FCF is now -2212.29% below its all-time high of -$7.26 million, reached on March 31, 2019.
Performance
ARQT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ARQT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | +20.9% | +36.1% |
| 3 y3 years | -118.3% | +20.9% | +36.1% |
| 5 y5 years | -1657.1% | +20.9% | +36.1% |
ARQT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.9% | +11.9% | -10.2% | +61.6% | at high | +45.7% |
| 5 y | 5-year | -473.8% | +11.9% | -106.5% | +61.6% | -289.1% | +45.7% |
| alltime | all time | -6455.9% | +11.9% | -380.0% | +61.6% | -2212.3% | +45.7% |
Arcutis Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.83 M(-22.8%) | -$167.80 M(-5.2%) |
| Jun 2024 | - | -$45.12 M(+42.8%) | -$177.02 M(-10.9%) |
| Mar 2024 | - | -$31.60 M(-43.8%) | -$198.66 M(-19.7%) |
| Dec 2023 | -$247.49 M(-11.9%) | -$56.25 M(+27.7%) | -$247.49 M(-5.7%) |
| Sep 2023 | - | -$44.05 M(-34.0%) | -$262.42 M(-15.1%) |
| Jun 2023 | - | -$66.76 M(-17.0%) | -$309.03 M(+1.5%) |
| Mar 2023 | - | -$80.43 M(+13.0%) | -$304.32 M(+8.3%) |
| Dec 2022 | -$281.00 M(+60.0%) | -$71.19 M(-21.5%) | -$281.00 M(+7.3%) |
| Sep 2022 | - | -$90.65 M(+46.1%) | -$261.78 M(+23.4%) |
| Jun 2022 | - | -$62.06 M(+8.7%) | -$212.15 M(+14.1%) |
| Mar 2022 | - | -$57.10 M(+9.9%) | -$185.96 M(+5.9%) |
| Dec 2021 | -$175.62 M | -$51.97 M(+26.7%) | -$175.62 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$41.02 M(+14.3%) | -$156.38 M(+4.8%) |
| Jun 2021 | - | -$35.87 M(-23.3%) | -$149.16 M(+7.3%) |
| Mar 2021 | - | -$46.76 M(+42.9%) | -$139.06 M(+22.7%) |
| Dec 2020 | -$113.35 M(+162.8%) | -$32.72 M(-3.2%) | -$113.35 M(+16.3%) |
| Sep 2020 | - | -$33.80 M(+31.1%) | -$97.49 M(+31.0%) |
| Jun 2020 | - | -$25.78 M(+22.5%) | -$74.42 M(+30.7%) |
| Mar 2020 | - | -$21.05 M(+24.8%) | -$56.92 M(+32.0%) |
| Dec 2019 | -$43.13 M(+206.2%) | -$16.86 M(+57.2%) | -$43.13 M(+64.2%) |
| Sep 2019 | - | -$10.73 M(+29.5%) | -$26.27 M(+69.0%) |
| Jun 2019 | - | -$8.29 M(+14.2%) | -$15.54 M(+114.2%) |
| Mar 2019 | - | -$7.26 M | -$7.26 M |
| Dec 2018 | -$14.09 M(+273.1%) | - | - |
| Dec 2017 | -$3.77 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual FCF year-on-year change?
- What is Arcutis Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
- What is Arcutis Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM FCF year-on-year change?
What is Arcutis Biotherapeutics annual free cash flow?
The current annual FCF of ARQT is -$247.49 M
What is the all time high annual FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual free cash flow is -$3.77 M
What is Arcutis Biotherapeutics annual FCF year-on-year change?
Over the past year, ARQT annual free cash flow has changed by +$33.51 M (+11.93%)
What is Arcutis Biotherapeutics quarterly free cash flow?
The current quarterly FCF of ARQT is -$34.83 M
What is the all time high quarterly FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly free cash flow is -$7.26 M
What is Arcutis Biotherapeutics quarterly FCF year-on-year change?
Over the past year, ARQT quarterly free cash flow has changed by +$9.22 M (+20.92%)
What is Arcutis Biotherapeutics TTM free cash flow?
The current TTM FCF of ARQT is -$167.80 M
What is the all time high TTM FCF for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM free cash flow is -$7.26 M
What is Arcutis Biotherapeutics TTM FCF year-on-year change?
Over the past year, ARQT TTM free cash flow has changed by +$94.62 M (+36.06%)